Cargando…
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13
In this latest update we highlight a report from the European Medicines Agency on their use of real-world evidence (RWE) in decision making, RWE reporting guidance from the Canadian Agency for Drugs and Technologies in Health and highlight some new data demonstrating the value medicines for spinal m...
Autores principales: | Bray, Benjamin D, Ramagopalan, Sreeram V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Becaris Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690375/ https://www.ncbi.nlm.nih.gov/pubmed/37712636 http://dx.doi.org/10.57264/cer-2023-0141 |
Ejemplares similares
-
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12
por: Bray, Ben, et al.
Publicado: (2023) -
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11
por: Bray, Ben, et al.
Publicado: (2023) -
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
por: Simpson, Alex, et al.
Publicado: (2022) -
Access in all areas? A round up of developments in market access and health technology assessment: part 1
por: Gilardino, Ramiro, et al.
Publicado: (2023) -
Barriers impacting the POINT pragmatic trial: the unavoidable overlap between research and intervention procedures in “real-world” research
por: Dir, Allyson L., et al.
Publicado: (2021)